Related Experiment Video

Updated: Aug 10, 2026

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

The judicious use of antibiotic agents in common childhood respiratory illness

M L Manning1, L M Bell

  • 1Departments of Infection Control and Occupational Health, Children's Hospital of Philadelphia, Pennsylvania 19104, USA.

The Nursing Clinics of North America
|February 16, 2000
PubMed

Insights

Widespread antimicrobial use fuels bacterial resistance, especially when treating children's respiratory infections. This article guides judicious antimicrobial prescribing for common childhood illnesses to combat resistance.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pharmacology

Background:

  • Antimicrobial resistance is a growing global health threat.
  • Inappropriate antimicrobial use is common for pediatric respiratory tract infections.
  • This contributes significantly to the development of resistant bacterial strains.

Purpose of the Study:

  • To review the appropriate use of antimicrobial agents in pediatric respiratory illnesses.
  • To provide guidance on judicious prescribing to mitigate antimicrobial resistance.
  • To address common conditions including otitis media, sinusitis, pharyngitis, bronchitis, and the common cold.

Main Methods:

  • Literature review of antimicrobial resistance patterns.
  • Analysis of current treatment guidelines for pediatric respiratory infections.
  • Discussion of evidence-based prescribing practices.

Main Results:

  • Antimicrobial agents are frequently overprescribed for viral infections.
  • Specific diagnostic criteria and treatment durations are essential for appropriate use.
  • Judicious prescribing can significantly reduce unnecessary antimicrobial exposure.

Conclusions:

  • Optimizing antimicrobial use in children is critical to curb resistance.
  • Adherence to guidelines for common respiratory infections is paramount.
  • Stewardship programs are vital for preserving antimicrobial efficacy.

More Related Videos

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases03:22

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

Related Concept Videos

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...